1. Home
  2. AXIL vs SRTS Comparison

AXIL vs SRTS Comparison

Compare AXIL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

HOLD

Current Price

$5.55

Market Cap

45.0M

ML Signal

HOLD

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

N/A

Current Price

$3.04

Market Cap

44.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXIL
SRTS
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
44.3M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
AXIL
SRTS
Price
$5.55
$3.04
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.00
AVG Volume (30 Days)
8.3K
33.6K
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$26,257,522.00
$27,482,000.00
Revenue This Year
N/A
$2.00
Revenue Next Year
N/A
$34.23
P/E Ratio
$37.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$2.66
52 Week High
$10.25
$5.92

Technical Indicators

Market Signals
Indicator
AXIL
SRTS
Relative Strength Index (RSI) 43.48 51.36
Support Level $4.78 $2.87
Resistance Level $7.26 $3.11
Average True Range (ATR) 0.47 0.12
MACD -0.03 0.02
Stochastic Oscillator 49.41 41.27

Price Performance

Historical Comparison
AXIL
SRTS

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: